Arrowhead Research | ARWR - Market Capitalization


Arrowhead Research reported $5.87B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 1.61B 598M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 5.87B 5.63B Nov/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 24.6B 1.95B Sep/2026
Ionis Pharmaceuticals USD 4.52B 2.9B Nov/2026
Ligand Pharmaceuticals USD 6.23B 108M Sep/2026
Merck USD 375.59B 17.09B Nov/2026
Moderna USD 99.14B 22.26B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 292.09B 51.5B Sep/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
TG Therapeutics USD 9.79B 1.25B Nov/2026
Ultragenyx Pharmaceutical USD 1.37B 108M Nov/2026
Vertex Pharmaceuticals USD 140.44B 7.93B Nov/2026
Xencor USD 2.14B 281M Nov/2026